Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis

Semin Oncol Nurs. 2004 Feb;20(1):3-10. doi: 10.1053/j.soncn.2003.10.002.

Abstract

Objective: To discuss the scope and epidemiology of cancer therapy-induced mucositis.

Data source: Peer-reviewed articles and book chapters.

Conclusion: Mucositis is a frequent and costly complication of cancer treatment. The risk of cancer therapy-induced mucositis varies depending on a number of patient- and treatment-related factors.

Implications for nursing practice: An awareness of the risk factors associated with mucositis will allow nurses to identify cancer patients at greatest risk and incorporate supportive care measures into their management plans.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Cost of Illness
  • Gastrointestinal Diseases / economics
  • Gastrointestinal Diseases / epidemiology*
  • Gastrointestinal Diseases / etiology
  • Gastrointestinal Diseases / nursing
  • Health Care Costs / statistics & numerical data
  • Health Resources / economics
  • Health Resources / statistics & numerical data
  • Humans
  • Incidence
  • Mouth Mucosa
  • Neoplasms* / complications
  • Neoplasms* / therapy
  • Nurse's Role
  • Nursing Assessment
  • Oncology Nursing / methods
  • Oral Hygiene
  • Patient Care Planning
  • Quality of Life
  • Radiotherapy / adverse effects
  • Risk Factors
  • Stomatitis / economics
  • Stomatitis / epidemiology*
  • Stomatitis / etiology
  • Stomatitis / nursing

Substances

  • Antineoplastic Agents